EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Asia Pacific

Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug

US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and safety of a diabetes drug candidate originall...
4 April 2018 Asia Pacific | Europe clinical | diabetes
Continue Reading →
Asia Pacific

Pelican BioThermal To Open New Tokyo Service Center

New location to service rapidly expanding Crēdo™ on Demand rental program   Pelican BioThermal, the global name in temperature controlled packaging, announces th...
4 April 2018 Asia Pacific | Europe biothermal | center
Continue Reading →
Asia Pacific

Esco, Max Planck cooperate on research of flavivirus vaccines

The purpose of the project is to culture Vero cells, using a packed bed bioreactor to a high cell density, and produce live attenuated yellow fever virus (YFV). Esco ...
4 April 2018 Asia Pacific | Europe Esco | flavivirus
Continue Reading →
Asia Pacific

Shionogi to Modernize Product Quality Management in the Cloud with Veeva Vault QMS

Pharmaceutical company in Japan unifies product quality management processes across global stakeholders Veeva Systems today announced that Shionogi & Co., Ltd., a...
28 March 2018 Asia Pacific | Europe management | product
Continue Reading →
Asia Pacific

Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X–Linked Hypophosphatemia in Children

Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx...
27 February 2018 Asia Pacific | Europe | news
Continue Reading →
Asia Pacific

Scientists in Korea develop biosensing lens for diabetics

The research team expects that the release of this device will offer diabetics a pain-free way to measure their glucose levels with the blink of an eye. [caption id="...
27 February 2018 Asia Pacific | news
Continue Reading →
Asia Pacific

TWi Biotechnology gets TFDA nod to treat Inherited Epidermolysis Bullosa

TFDA approves phase 2 clinical trial of AC-203 for the treatment of inherited Epidermolysis Bullosa (EB) TWi Biotechnology,a clinical stage biotechnology company foc...
27 February 2018 Asia Pacific | news
Continue Reading →
Asia Pacific

New live attenuated TB vaccine is safe and shows a distinct, dose dependent immune response in a Phase1b trial in newborns

Biofabri, the University of Zaragoza, the South African Tuberculosis Vaccine Initiative (SATVI) and TB Vaccine Initiative (TBVI) announced the results of a Phase 1b t...
22 February 2018 Asia Pacific | Europe | news
Continue Reading →
Asia Pacific

Researchers in Japan develop a novel biosensing method

The group has developed a nonlinear optical crystal (NLOC) chip, which combines terahertz (THz) waves with a microfluidic device. A group of researchers from Osaka U...
21 February 2018 Asia Pacific | news
Continue Reading →
Asia Pacific

Eli Lilly discontinues Ph II trials for arthritis drug

In March 2015, Hanmi signed an exclusive license agreement with the US-based drug maker to grant rights to HM71224 in a deal that could generate up to $640 million K...
21 February 2018 Asia Pacific | news
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte